Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025)
Carlsmed (CARL) posted Net Equity Issued and Repurchased of $11.9 million for Q1 2025, up 36218.18% on a QoQ basis from -$33000.0 in Q4 2024.
Carlsmed (CARL) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
Carlsmed's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $11.9 million for Q1 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $11.9 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $11.9 million (changed N/A YoY) and the FY2025 annual result came in at $11.9 million, down 77.19% from the prior year.
- Net Equity Issued and Repurchased was $11.9 million for Q1 2025 at Carlsmed, up from -$33000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $14.0 million in Q3 2024 and bottomed at -$132000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | - |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Carlsmed | 307.54 Mn | 234.42 Mn | 12.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 11.92 Mn |
| Mar 31, 2025 | 11.92 Mn |
| Dec 31, 2024 | -33,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 14.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | -132,000.00 |
| Jun 30, 2024 | -132,000.00 |